Ligand validation:4IXQ

SQD: 1,2-DI-O-ACYL-3-O-[6-DEOXY-6-SULFO-ALPHA-D-GLUCOPYRANOSYL]-SN-GLYCEROL

SQD is a Ligand Of Interest in 4IXQ designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4IXQ_SQD_A_413	5%	35%	0.34	0.755	0.98	1.55	6	9	0	0	94%	0.9444
4IXQ_SQD_A_417	5%	34%	0.371	0.773	1.02	1.58	5	11	0	0	100%	1
4IXQ_SQD_B_625	3%	33%	0.381	0.763	1.04	1.58	5	10	0	0	87%	0.8704
4IXQ_SQD_a_415	3%	35%	0.377	0.742	1	1.56	5	10	0	0	94%	0.9444
4IXQ_SQD_b_601	3%	33%	0.384	0.733	1.04	1.61	5	9	0	0	87%	0.8704
4IXQ_SQD_a_401	2%	34%	0.449	0.731	0.98	1.59	5	11	0	0	100%	1
4IXQ_SQD_D_409	1%	23%	0.581	0.716	1.11	2.02	4	10	0	0	80%	0.7963
4IXQ_SQD_f_103	0%	32%	0.673	0.734	1.04	1.66	5	11	0	0	83%	0.8333
4IXQ_SQD_F_102	0%	31%	0.694	0.688	1.05	1.69	5	10	0	0	83%	0.8333
4IXQ_SQD_d_407	0%	23%	0.862	0.661	1.13	2.03	4	10	0	0	80%	0.7963
5V2C_SQD_a_413	94%	21%	0.075	0.976	1.12	2.14	4	12	0	0	100%	1
6DHE_SQD_A_412	78%	20%	0.113	0.961	1.05	2.27	5	14	0	0	96%	0.963
8IRC_SQD_a_411	77%	29%	0.119	0.96	0.96	1.83	3	13	0	0	100%	1
8IR5_SQD_a_411	76%	31%	0.123	0.958	0.95	1.77	3	13	0	0	100%	1
8IRF_SQD_a_410	76%	29%	0.125	0.96	0.96	1.83	3	13	0	0	100%	0.49
8IR8_SQD_a_409	75%	31%	0.126	0.96	0.95	1.77	3	13	0	0	100%	0.4

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.